1. Home
  2. EVOK vs POLA Comparison

EVOK vs POLA Comparison

Compare EVOK & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • POLA
  • Stock Information
  • Founded
  • EVOK 2007
  • POLA 1979
  • Country
  • EVOK United States
  • POLA United States
  • Employees
  • EVOK N/A
  • POLA N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • EVOK Health Care
  • POLA Miscellaneous
  • Exchange
  • EVOK Nasdaq
  • POLA Nasdaq
  • Market Cap
  • EVOK 7.1M
  • POLA 8.3M
  • IPO Year
  • EVOK 2013
  • POLA 2016
  • Fundamental
  • Price
  • EVOK $5.37
  • POLA $2.83
  • Analyst Decision
  • EVOK
  • POLA
  • Analyst Count
  • EVOK 0
  • POLA 0
  • Target Price
  • EVOK N/A
  • POLA N/A
  • AVG Volume (30 Days)
  • EVOK 8.9K
  • POLA 10.8K
  • Earning Date
  • EVOK 03-13-2025
  • POLA 11-14-2024
  • Dividend Yield
  • EVOK N/A
  • POLA N/A
  • EPS Growth
  • EVOK N/A
  • POLA N/A
  • EPS
  • EVOK N/A
  • POLA N/A
  • Revenue
  • EVOK $8,617,036.00
  • POLA $14,953,000.00
  • Revenue This Year
  • EVOK $97.35
  • POLA $6.72
  • Revenue Next Year
  • EVOK $99.52
  • POLA N/A
  • P/E Ratio
  • EVOK N/A
  • POLA N/A
  • Revenue Growth
  • EVOK 100.35
  • POLA N/A
  • 52 Week Low
  • EVOK $3.54
  • POLA $2.31
  • 52 Week High
  • EVOK $12.32
  • POLA $4.90
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 65.36
  • POLA 43.70
  • Support Level
  • EVOK $4.68
  • POLA $2.74
  • Resistance Level
  • EVOK $5.40
  • POLA $2.92
  • Average True Range (ATR)
  • EVOK 0.33
  • POLA 0.10
  • MACD
  • EVOK 0.07
  • POLA -0.01
  • Stochastic Oscillator
  • EVOK 97.46
  • POLA 27.42

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.

Share on Social Networks: